CPRIT PDR — Texas Seed Company
Funds early Texas oncology companies in seed stages while strengthening oncology-specific research development.
The Cancer Prevention and Research Institute of Texas (CPRIT) Texas Seed Company RFA is the entry-level track within the Product Development Research program, which deploys approximately $70 million per fiscal year to Texas oncology companies. The Seed RFA funds company formation and early-stage research and development across all oncology product categories — therapeutics, devices, diagnostics, a…
Company formation and early-stage R&D of novel oncology therapeutics, devices, diagnostics, and enabling tools in Texas, capped at $3 million per project.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
BudgetGrant Financials and Co-Funding Evidence: Examples for Startup Applications
See examples of grant financials, match funding evidence, co-funding tables, accountant letters, investor commitments, and budget-to-work-plan checks.
Start hereTRL Levels Explained for Deeptech Founders
Learn what TRL levels mean, how to estimate technology readiness, and how TRL affects grants, EIC Accelerator, SBIR/STTR, funding stage, and application evidence.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
More from CPRIT
All grants from this funder →CPRIT Prevention — Cancer Screening and Early Detection
🇺🇸CPRIT · United States
Funds Texas cancer screening and early detection networks to strengthen evidence-based diagnosis pathways.
CPRIT Prevention — Dissemination of Cancer Control Interventions
🇺🇸CPRIT · United States
Funds Texas prevention programs scaling proven cancer initiatives into new communities and settings.
CPRIT Prevention — Primary Prevention of Cancer
🇺🇸CPRIT · United States
Funds Texas primary prevention projects reducing cancer risk through layered interventions and outreach.
CPRIT Scholars — Recruitment of Established Investigators
🇺🇸CPRIT · United States
Funds Texas universities to recruit established cancer researchers and build strong senior leadership labs.
CPRIT Scholars — Recruitment of First-Time, Tenure-Track Faculty
🇺🇸CPRIT · United States
Funds Texas universities to hire first-time tenure-track cancer researchers and grow research portfolios.
CPRIT Scholars — Recruitment of Rising Stars
🇺🇸CPRIT · United States
Funds Texas universities attracting mid-career cancer talent and strengthening high-quality oncology groups.
Similar grants
Browse the directory →
BIRD General Program
🇺🇸BIRD Foundation · United States
Supports United States and Israel partners to jointly commercialize hi-tech innovation, including cybersecurity, life sciences, and manufacturing.
Global Access Program
🇺🇸PA DCED · United States
Funds Pennsylvania companies expanding export sales through reimbursement grants for eligible international business development costs.
NIH CRP Commercialization Readiness Pilot
🇺🇸NIH SEED · United States
Offers late stage commercialization readiness support through NIH CRP for small firms advancing biomedical health solutions.
NSF SBIR/STTR Fast-Track Pilot
🇺🇸NSF · United States
Supports United States deep-tech startups through a combined early and continuation development route.
NIH SBIR Direct-to-Phase II (Omnibus)
🇺🇸NIH · United States
Funds United States small businesses moving directly into major development when early biomedical feasibility is already established.
NSF SBIR Phase II
🇺🇸NSF · United States
Funds United States deep-tech startups extending proven early projects into substantial technology development.